Leah Kuntz

Government funding for the drug addiction crisis is on the way.

The first study to gather unsolicited patient responses via social media finds 3 negative themes.

Service animals can help save veterans’ lives.

This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.

As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.

An ex-Yale psychiatrist who skirted the Goldwater Rule is suing the university over her termination.

Misdiagnosis and late diagnosis may be preventing older patients with bipolar disorder from getting proper care.

This monoclonal antibody showed significant slowing of decline in patients with Alzheimer disease.

This social anxiety disorder treatment does not directly activate gamma-amino butyric acid (GABA-A) receptors, setting it apart from benzodiazepines.

It’s time for psychiatry to take the high road in addressing racism, especially as the psychological toll becomes more evident.

New data from the ongoing SHORELINE study may bring good news for treating MDD.

The International Psychogeriatric Association shares opportunities to improve worldwide geriatric care.

What socio-cultural events impacted the older LGBTQ+ generations, and how do they inform their current mental health status?

Should a patient at the end of her life have access to psilocybin, even if it’s illegal?

The chief medical officer of Karuna shares his thoughts exclusively with Psychiatric Times.

The FDA has approved the New Drug Application for a once-daily ADHD treatment.

If approved, this formulation of sodium oxybate will be the first once-nightly oxybate treatment for daytime sleepiness.

A new study considers how the virus might enter the brain and cause cognitive issues.

If approved by the FDA, this treatment would be the first therapy for treating depressive episodes in both bipolar I and II disorder in 2 different forms.

An alcohol use disorder treatment has 4 potential advantages over existing treatments.

What black physicians have influenced the mental health field, changing it for good?

A study on a new Alzheimer disease vaccine lacks concrete numbers.

The American Heart Association released a statement recognizing the importance of the relationship between mental well-being and cardiovascular disease.

Is the purported “saddest day of the year” evidence-based?

The Department of Health and Human Services moves to reduce administrative procedural barriers to OUD treatment.

Researchers have discovered a gene signaling pathway associated with a higher risk for developing schizophrenia.

Improving physical activity levels and eating habits could help patients with schizophrenia.

In an ADAPT-2 study, a combination of injectable naltrexone and oral bupropion showed promise for methamphetamine users.

The RISE study results look promising.

Major psychiatry organizations condemn the actions and events of January 6th.